KLI

검색

Ulsan Univ. Repository

Browsing by 저자 : Hyung-Don Kim

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

또는 첫 단어:

정렬 기준:
정렬:
결과 수
저자 수

전체 결과 26건 중 1-26 번을 표시중입니다.

1 Article 4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8(+) T Cells in Hepatocellular Carcinoma 송기원 ; 홍승모 ; 황신 ; et al 2020
2 Article A randomised phase 2 study of continuous or intermittent dosing schedule of imatinib re-challenge in patients with tyrosine kinase inhibitor-refractory gastrointestinal stromal tumours Hyung-Don Kim ; Changhoon Yoo ; Min-Hee Ryu ; et al 2023
3 Article Adjuvant Imatinib Treatment for 5 Years versus 3 Years in Patients with Ruptured Localized Gastrointestinal Stromal Tumor: A Retrospective Analysis Sora Kang ; Min-Hee Ryu ; Yeong Hak Bang ; et al 2022
4 Article Association between HER2 heterogeneity and clinical outcomes of HER2?positive gastric cancer patients treated with trastuzumab Kyunghye Bang ; Jaekyung Cheon ; Young Soo Park ; et al 2022
5 Article BRCA-mutated gastric adenocarcinomas are associated with chromosomal instability and responsiveness to platinum-based chemotherapy Ji Hyun Oh ; Chang Ohk Sung ; Hyung-Don Kim ; et al 2023
6 Article Cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis Jihyun An ; Hyung-Don Kim ; Seon-Ok Kim ; et al 2022
7 Article Clinical implications of the tumor microenvironment using multiplexed immunohistochemistry in patients with advanced or metastatic renal cell carcinoma treated with nivolumab plus ipilimumab Jwa Hoon Kim ; Gi Hwan Kim ; Yeon-Mi Ryu ; et al 2022
8 Article Clinical outcomes and prognostic factors for patients with high-risk gastrointestinal stromal tumors treated with 3-year adjuvant imatinib Yeong Hak Bang ; Min-Hee Ryu ; Hyung-Don Kim ; et al 2022
9 Article Clinical outcomes of immune checkpoint inhibitors in unresectable or metastatic combined hepatocellular-cholangiocarcinoma Yoon Jung Jang ; Eo Jin Kim ; Hyung-Don Kim ; et al 2023
10 Article Clinicopathologic features and prognostic value of claudin 18.2 overexpression in patients with resectable gastric cancer Hyung-Don Kim ; Eugene Choi ; Jinho Shin ; et al 2023
11 Article Determinants of clinical outcomes of gastric cancer patients treated with neoadjuvant chemotherapy: a sub-analysis of the PRODIGY study Hyung-Don Kim ; Jong Seok Lee ; Young Soo Park ; et al 2022
12 Article Dynamic changes in peripheral blood monocytes early after anti-PD-1 therapy predict clinical outcomes in hepatocellular carcinoma Seung Hyuck Jeon ; Yong Joon Lee ; Hyung-Don Kim ; et al 2023
13 Article Dynamic increase of M2 macrophages is associated with disease progression of colorectal cancers following cetuximab-based treatment Hyung-Don Kim ; Sun Young Kim ; Jihun Kim ; et al 2022
14 Article Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation Kyunghye Bang ; Andrea Casadei-Gardini ; Changhoon Yoo ; et al 2023
15 Article Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor-Positive Metastatic Breast Cancer Seul-Gi Kim ; Min Hwan Kim ; Sejung Park ; et al 2023
16 Article Epithelial-Mesenchymal Transition Phenotype and Peritumoral Immune Cell Infiltration in Advanced Biliary Tract Cancer Chung Ryul Oh ; Hyung-Don Kim ; Yeon-Mi Ryu ; et al 2023
17 Article Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance Eunyoung Tak ; Minhee Kim ; Youngra Cho ; et al 2022
18 Article Insertion-deletion rate is a qualitative aspect of the tumor mutation burden associated with the clinical outcomes of gastric cancer patients treated with nivolumab Hyung-Don Kim ; Min-Hee Ryu ; Young Soo Park ; et al 2022
19 Article Interruption of imatinib in advanced gastrointestinal stromal tumor after prolonged imatinib maintenance in the absence of gross tumor lesions Yoon-Koo Kang ; Hyung-Don Kim ; Hyun Jin Kim ; et al 2023
20 Article Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach Tae-Han Kim ; In-Ho Kim ; Seung Joo Kang ; et al 2023
21 Article Prognostic significance of serum β2-microglobulin levels in patients with peripheral T-cell lymphoma not otherwise specified Hyung-Don Kim ; Hyungwoo Cho ; Byeong Seok Sohn ; et al 2022
22 Article Prognostic value of natural killer cell activity for patients with HER2+advanced gastric cancer treated with first-line fluoropyrimidine-platinum doublet plus trastuzumab Hyungwoo Cho ; Min-Hee Ryu ; Hyung Eun Lee ; et al 2022
23 Article Radiological criteria for selecting candidates for neoadjuvant chemotherapy for gastric cancer: an exploratory analysis from the PRODIGY study Hyung-Don Kim ; Jong Seok Lee ; Jeong Hwan Yook ; et al 2022
24 Article Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis Yeong Hak Bang ; Choong-kun Lee ; Changhoon Yoo ; et al 2022
25 Article The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery Hyehyun Jeong ; Kye Jin Park ; Yongjune Lee ; et al 2022
26 Article Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma Samuel Chuah ; Joycelyn Lee ; Yuan Song ; et al 2022

OAK Ulsan Univ. Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.